Physician profile
Daniel E Lee
NPI 1043241672
$2,240.03
in general payments reported to CMS, 2019-2025
21 companies · $698 in 2025
The $698 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $463 · 2023: $466 · 2024: $479 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,642.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $402.22 | 2022-2025 | Mounjaro, Zepbound, Kisunla |
| Astrazeneca Pharmaceuticals LP | $278.98 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $245.64 | 2022-2025 | Wegovy, Ozempic, Saxenda |
| Pfizer INC. | $165.22 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $147.39 | 2022-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Glaxosmithkline, LLC. | $145.88 | 2022-2025 | Bexsero, Trelegy Ellipta |
| Si-Bone, INC. | $133.58 | 2021 | |
| Sumitomo Pharma America, INC. | $123.86 | 2024-2025 | Gemtesa |
| Abbvie INC. | $109.41 | 2022-2025 | |
| Exact Sciences Corporation | $93.36 | 2023-2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $89.50 | 2022-2024 | |
| Daiichi Sankyo INC. | $53.77 | 2022-2023 | Injectafer |
| Corium, LLC | $50.44 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $47.83 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $45.99 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $25.33 | 2025 | Inspire |
| Mayne Pharma Commercial LLC | $22.39 | 2022 | |
| Depuy Synthes Sales INC. | $17.65 | 2024 | Orthovisc |
| Edwards Lifesciences Corporation | $15.00 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.78 | 2022 | |
| Phathom Pharmaceuticals, INC. | $12.81 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.